Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015 Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …
News
asthma inhalers

New study reveals true impact of severe asthma in Europe

September 29, 2015 Research and Development ERS2015, asthma

The results of a new, comprehensive survey have revealed the true burden of severe asthma faced by patients across Europe. …
News
Opdivo

Bristol-Myers Squibb notches kidney cancer first with Opdivo

September 28, 2015 Research and Development Afinitor, Bristol-Myers Squibb, Kidney cancer, advanced kidney cancer, everolimus, nivolumab, opdivo, renal cell carcinoma

Bristol-Myers Squibb has announced positive results from a Phase III study comparing Opdivo to Afinitor, the Novartis treatment that is …
News
glioblastoma

ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma

September 25, 2015 Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma

ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …
News

Novartis’ new heart failure medicine recommended for EU approval

September 25, 2015 Medical Communications, Research and Development Entresto, Novartis, eams, heart failure

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’s heart failure medication Entresto …
News
velocity_health

Merck and Wayra to tackle NHS funding gap with startup rewards programme

September 25, 2015 Research and Development MSD, Merck

Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …
News
copd

Genetic study reveals new associations with lung disease and smoking behaviour

September 25, 2015 Medical Communications, Research and Development COPD, lung cancer, smkoing

New research published in The Lancet Respiratory Medicine and presented at this year’s European Respiratory Society (ERS) Congress in Amsterdam …
News
BI building

Boehringer and BioMed X crowdsource top scientists to fight COPD

September 23, 2015 Research and Development Boehringer Ingelheim, COPD

Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …
News
HIV infected cell

ViiV in late-stage HIV trial success

September 23, 2015 Research and Development HIV, Triumeq, ViiV, virology

Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …
News

Pharma ‘is getting better at drug R&D’

September 23, 2015 Research and Development R&D, drug development, market access, productivity

An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …
News
scottish_highlands

Vision for hi-tech manufacturing in the Scottish highlands

September 22, 2015 Manufacturing and Production, Research and Development GSK, Scotland, manufacturing

Scottish life and chemical science firms claim Scotland is an ideal European base for UK and global manufacturers. A new …
News
Esbriet

Roche to present new Esbriet data at ERS Congress 2015

September 21, 2015 Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone

Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …
News
Jardiance

More positive CV data for Boehringer and Lilly’s Jardiance

September 21, 2015 Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes

Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …
News

Biocair opens new site in Belgium

September 21, 2015 Research and Development, Sales and Marketing Biocair

Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …
News
Press release

FDA grants Opdivo breakthrough status for kidney cancer

September 18, 2015 Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma

The FDA has given Bristol-Myers Squibb’s immuno-oncology drug Opdivo Breakthrough Therapy Designation as a kidney cancer treatment. The FDA’s decision …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025